Home » Topics » BioWorld Science

BioWorld Science
RSS

Muscarinic acetylcholine M3 receptor positive allosteric modulators patented by Nippon Shinyaku

Nov. 27, 2019

Janssen Pharmaceutica presents dual SGLT1 and SGLT2 inhibitors

Nov. 27, 2019

New monocarboxylate transporter 4 inhibitors identified at AstraZeneca

Nov. 27, 2019

Dizal Pharmaceutical describes new HER2 inhibitors

Nov. 27, 2019

Preliminary phase I/II data presented for olutasidenib in advanced IDH1-mutant gliomas

Nov. 27, 2019

NOTCH3 expression as a predictor of poor survival in patients with ESCC

Nov. 27, 2019

Targeting miR-26a shows therapeutic potential in model of abdominal aortic aneurysm

Nov. 27, 2019

Successful completion of Stage 2 of phase II study of prexigebersen plus decitabine in AML

Nov. 27, 2019

FDA approves Exservan oral film for the treatment of ALS

Nov. 27, 2019

DNDi receives financial support development of drugs for sleeping sickness and river blindness

Nov. 27, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 6, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...